MOLECULAR PARTNERS AG -ADR (MOLN) Fundamental Analysis & Valuation

NASDAQ:MOLN • US60853G1067

Current stock price

4.18 USD
0 (0%)
Last:

This MOLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MOLN Profitability Analysis

1.1 Basic Checks

  • MOLN had negative earnings in the past year.
  • MOLN had a negative operating cash flow in the past year.
  • In the past 5 years MOLN reported 4 times negative net income.
  • In the past 5 years MOLN reported 4 times negative operating cash flow.
MOLN Yearly Net Income VS EBIT VS OCF VS FCFMOLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • The Return On Assets of MOLN (-60.38%) is comparable to the rest of the industry.
  • MOLN's Return On Equity of -76.74% is in line compared to the rest of the industry. MOLN outperforms 50.00% of its industry peers.
Industry RankSector Rank
ROA -60.38%
ROE -76.74%
ROIC N/A
ROA(3y)-41.91%
ROA(5y)-23.54%
ROE(3y)-50.01%
ROE(5y)-31.87%
ROIC(3y)N/A
ROIC(5y)N/A
MOLN Yearly ROA, ROE, ROICMOLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for MOLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MOLN Yearly Profit, Operating, Gross MarginsMOLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -200 -400 -600 -800 -1K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. MOLN Health Analysis

2.1 Basic Checks

  • MOLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MOLN has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for MOLN has been increased compared to 5 years ago.
  • Compared to 1 year ago, MOLN has a worse debt to assets ratio.
MOLN Yearly Shares OutstandingMOLN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
MOLN Yearly Total Debt VS Total AssetsMOLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

  • MOLN has an Altman-Z score of -1.68. This is a bad value and indicates that MOLN is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.68, MOLN is in line with its industry, outperforming 50.39% of the companies in the same industry.
  • A Debt/Equity ratio of 0.03 indicates that MOLN is not too dependend on debt financing.
  • MOLN has a Debt to Equity ratio of 0.03. This is comparable to the rest of the industry: MOLN outperforms 43.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -1.68
ROIC/WACCN/A
WACC4.88%
MOLN Yearly LT Debt VS Equity VS FCFMOLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • MOLN has a Current Ratio of 8.79. This indicates that MOLN is financially healthy and has no problem in meeting its short term obligations.
  • MOLN's Current ratio of 8.79 is fine compared to the rest of the industry. MOLN outperforms 75.19% of its industry peers.
  • A Quick Ratio of 8.79 indicates that MOLN has no problem at all paying its short term obligations.
  • MOLN has a Quick ratio of 8.79. This is in the better half of the industry: MOLN outperforms 75.19% of its industry peers.
Industry RankSector Rank
Current Ratio 8.79
Quick Ratio 8.79
MOLN Yearly Current Assets VS Current LiabilitesMOLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MOLN Growth Analysis

3.1 Past

  • MOLN shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.69%.
  • Looking at the last year, MOLN shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-5.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.17%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • MOLN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.11% yearly.
  • The Revenue is expected to grow by 133.77% on average over the next years. This is a very strong growth
EPS Next Y12.23%
EPS Next 2Y46.65%
EPS Next 3Y2.49%
EPS Next 5Y2.11%
Revenue Next Year285.71%
Revenue Next 2Y327.62%
Revenue Next 3Y98.8%
Revenue Next 5Y133.77%

3.3 Evolution

MOLN Yearly Revenue VS EstimatesMOLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 100M 200M 300M 400M
MOLN Yearly EPS VS EstimatesMOLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 2 -2 3

More info and screens

Find the best growth stocksShow best growing peers

0

4. MOLN Valuation Analysis

4.1 Price/Earnings Ratio

  • MOLN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MOLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MOLN Price Earnings VS Forward Price EarningsMOLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MOLN Per share dataMOLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.65%
EPS Next 3Y2.49%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MOLN Dividend Analysis

5.1 Amount

  • MOLN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MOLN Fundamentals: All Metrics, Ratios and Statistics

MOLECULAR PARTNERS AG -ADR

NASDAQ:MOLN (4/17/2026, 10:06:41 AM)

4.18

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-12
Earnings (Next)N/A
Inst Owners44.16%
Inst Owner Change0%
Ins Owners4%
Ins Owner ChangeN/A
Market Cap156.33M
Revenue(TTM)N/A
Net Income(TTM)-61.65M
Analysts82
Price Target11.97 (186.36%)
Short Float %0.05%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.32%
PT rev (3m)-9.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)5.22%
EPS NY rev (3m)5.22%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.95%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.52
P/tB 1.52
EV/EBITDA N/A
EPS(TTM)-1
EYN/A
EPS(NY)-1.76
Fwd EYN/A
FCF(TTM)-1.77
FCFYN/A
OCF(TTM)-1.75
OCFYN/A
SpS0
BVpS2.74
TBVpS2.74
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -60.38%
ROE -76.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-41.91%
ROA(5y)-23.54%
ROE(3y)-50.01%
ROE(5y)-31.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.79
Quick Ratio 8.79
Altman-Z -1.68
F-Score1
WACC4.88%
ROIC/WACCN/A
Cap/Depr(3y)32.4%
Cap/Depr(5y)41.5%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.17%
EPS Next Y12.23%
EPS Next 2Y46.65%
EPS Next 3Y2.49%
EPS Next 5Y2.11%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year285.71%
Revenue Next 2Y327.62%
Revenue Next 3Y98.8%
Revenue Next 5Y133.77%
EBIT growth 1Y9.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year23.99%
EBIT Next 3Y-4.34%
EBIT Next 5YN/A
FCF growth 1Y13.34%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.49%
OCF growth 3YN/A
OCF growth 5YN/A

MOLECULAR PARTNERS AG -ADR / MOLN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of MOLECULAR PARTNERS AG -ADR (MOLN) stock?

ChartMill assigns a fundamental rating of 2 / 10 to MOLN.


What is the valuation status for MOLN stock?

ChartMill assigns a valuation rating of 0 / 10 to MOLECULAR PARTNERS AG -ADR (MOLN). This can be considered as Overvalued.


What is the profitability of MOLN stock?

MOLECULAR PARTNERS AG -ADR (MOLN) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for MOLN stock?

The Earnings per Share (EPS) of MOLECULAR PARTNERS AG -ADR (MOLN) is expected to grow by 12.23% in the next year.